T

Talis Biomedical Corp
NASDAQ:TLIS

Watchlist Manager
Talis Biomedical Corp
NASDAQ:TLIS
Watchlist
Price: 2.84 USD
Market Cap: 90m USD

Intrinsic Value

TLIS doesn't have a meaningful market cap.

There is not enough data to reliably calculate the intrinsic value of TLIS.

The Intrinsic Value is calculated as the average of DCF and Relative values:

TLIS Intrinsic Value
Not Available
Base Case Scenario
Compare TLIS to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about TLIS?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Talis Biomedical Corp

Current Assets 63.6m
Cash & Short-Term Investments 59.9m
Other Current Assets 3.7m
Non-Current Assets 9.1m
PP&E 8.3m
Other Non-Current Assets 766k
Current Liabilities 8.2m
Accounts Payable 3.8m
Accrued Liabilities 4.4m
Non-Current Liabilities 15.9m
Other Non-Current Liabilities 15.9m
Efficiency

Free Cash Flow Analysis
Talis Biomedical Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Talis Biomedical Corp

Revenue
408k USD
Cost of Revenue
-20k USD
Gross Profit
388k USD
Operating Expenses
-46.7m USD
Operating Income
-46.3m USD
Other Expenses
-4.7m USD
Net Income
-51m USD
Fundamental Scores

TLIS Profitability Score
Profitability Due Diligence

Talis Biomedical Corp's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Exceptional Gross Margin
Gross Margin is Increasing
Low 3Y Average Gross Margin
hidden
Profitability
Score

Talis Biomedical Corp's profitability score is hidden . The higher the profitability score, the more profitable the company is.

TLIS Solvency Score
Solvency Due Diligence

Talis Biomedical Corp's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Low Altman Z-Score
hidden
Solvency
Score

Talis Biomedical Corp's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

TLIS Price Targets Summary
Talis Biomedical Corp

There are no price targets for TLIS.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Talis Biomedical Corp
does not pay dividends
Shareholder Yield

Current shareholder yield for TLIS is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

TLIS Insider Trading
Buy and sell transactions by insiders